《彭博》引述消息指,内地政府要求部分国有制药企业研究如何减少对美国药品及原物料的依赖,此举正值北京方面在为应对可能威胁医疗供应链的脱钩风险做准备。报道称,国家药监局今年早些时候向国有制药企业高管传达了这一信息。该指令旨在评估替代美国制造的医疗产品的可行性。知情人士称,拟替代的产品范围广泛,包括用于生产药品的原料和辅料、实验室设备及检测试剂等,这些产品可通过国内生产或从日本等其他国家进口实现替代。...
Source Link《彭博》引述消息指,内地政府要求部分国有制药企业研究如何减少对美国药品及原物料的依赖,此举正值北京方面在为应对可能威胁医疗供应链的脱钩风险做准备。报道称,国家药监局今年早些时候向国有制药企业高管传达了这一信息。该指令旨在评估替代美国制造的医疗产品的可行性。知情人士称,拟替代的产品范围广泛,包括用于生产药品的原料和辅料、实验室设备及检测试剂等,这些产品可通过国内生产或从日本等其他国家进口实现替代。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.